Syndesi Therapeutics lands Series A funding
Syndesi Therapeutics, a Belgian neurology drug discovery startup, has raised 17 million euros in Series A funding. The investors included Novo Seeds, Fountain Healthcare, Johnson & Johnson Innovation – JJDC, Inc., V-BIO Ventures and the Walloon Investment Fund.
9 February 2018•1 min read
